WALTHAM, Mass.--(BUSINESS WIRE)--Sept. 14, 2006--NeuroMetrix, Inc. (NASDAQ: NURO), a medical device company focused on the development and sale of proprietary products used to diagnose neuropathies, announced today that it is scheduled to present at the AG Edwards’ Emerging Growth Conference at the New York Palace Hotel in New York City at 4:30pm (EST) on Wednesday, September 20, 2006. The audio presentation will be simultaneously available via webcast on the “Investors” home page at http://www.neurometrix.com.
